What is the recommended dosing for syphilis treatment?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: December 4, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Syphilis Treatment Dosing

For early syphilis (primary, secondary, or early latent), treat with a single intramuscular injection of benzathine penicillin G 2.4 million units, which is equally effective as three weekly doses and reduces treatment burden. 1

Primary and Secondary Syphilis

First-Line Treatment (Adults)

  • Benzathine penicillin G 2.4 million units IM as a single dose 2
  • Recent high-quality evidence demonstrates that one dose is noninferior to three weekly doses, with 76% serologic response at 6 months regardless of HIV status 1
  • This single-dose regimen reduces clinic visits, improves completion rates, and causes less injection-site pain compared to multiple doses 1

Pediatric Dosing (≥1 month old)

  • Benzathine penicillin G 50,000 units/kg IM (maximum 2.4 million units) as a single dose 2
  • Children require CSF examination to exclude neurosyphilis before treatment 2

Penicillin-Allergic Patients (Non-Pregnant)

  • Doxycycline 100 mg orally twice daily for 14 days (preferred alternative per CDC) 2, 3, 4
  • Tetracycline 500 mg orally four times daily for 14 days (more GI side effects, lower compliance) 2
  • Avoid azithromycin due to widespread T. pallidum resistance and documented treatment failures in the United States 2
  • Ceftriaxone 1 g IM or IV daily for 10-14 days may be considered, though optimal dosing remains undefined 2

Critical caveat: Pregnant patients with penicillin allergy must be desensitized and treated with penicillin—no alternatives are acceptable 2, 3

Latent Syphilis

Early Latent Syphilis (acquired within past year)

  • Benzathine penicillin G 2.4 million units IM as a single dose 2
  • Diagnosis requires documented seroconversion, recent symptoms of primary/secondary syphilis, or partner with early syphilis within the past year 2

Late Latent Syphilis or Unknown Duration

  • Benzathine penicillin G 2.4 million units IM weekly for 3 consecutive weeks (total 7.2 million units) 2
  • If a dose is missed, intervals up to 10-14 days between injections may be acceptable for non-pregnant patients 2
  • Pregnant patients cannot miss doses—restart the sequence if necessary 2

Pediatric Dosing for Latent Syphilis

  • Early latent: 50,000 units/kg IM (max 2.4 million units) as a single dose 2
  • Late latent/unknown duration: 50,000 units/kg IM (max 2.4 million units) weekly for 3 weeks (total 150,000 units/kg, max 7.2 million units) 2

Penicillin-Allergic Patients with Latent Syphilis

  • Early latent: Same alternatives as primary/secondary syphilis 2
  • Late latent/unknown duration: Doxycycline 100 mg orally twice daily for 28 days OR tetracycline 500 mg orally four times daily for 28 days 2, 3
  • These alternatives require close serologic and clinical follow-up 2

Neurosyphilis

Standard Regimen

  • Aqueous crystalline penicillin G 18-24 million units per day IV, administered as 3-4 million units every 4 hours (or continuous infusion) for 10-14 days 2, 5
  • Alternative: Procaine penicillin G 2.4 million units IM daily PLUS probenecid 500 mg orally four times daily, both for 10-14 days 2
  • Many experts recommend additional therapy with benzathine penicillin G 2.4 million units IM weekly for 3 doses after completing IV therapy 5

Syphilitic Eye Disease

  • Treat as neurosyphilis with the same IV penicillin regimen 2
  • Manage in collaboration with ophthalmology 2
  • Perform CSF examination on all patients with ocular syphilis 2

Pediatric Neurosyphilis

  • 200,000-300,000 units/kg/day IV (administered as 50,000 units/kg every 4-6 hours) for 10-14 days 5

Tertiary Syphilis (Non-Neurologic)

  • Benzathine penicillin G 2.4 million units IM weekly for 3 weeks (total 7.2 million units) 2
  • Perform CSF examination before treatment to exclude neurosyphilis 2
  • Cardiovascular syphilis may warrant neurosyphilis treatment regimen—consult infectious disease specialist 2

Follow-Up and Treatment Failure

Monitoring Schedule

  • Clinical and serologic evaluation at 6 months and 12 months after treatment for early syphilis 2
  • HIV-infected patients should be evaluated every 3 months instead of every 6 months 3
  • Late latent syphilis: evaluate at 6,12, and 24 months 3

Defining Treatment Failure

Treatment failure is suspected if: 2

  • Nontreponemal titers fail to decline fourfold (two dilutions) within 6 months for primary/secondary syphilis
  • Nontreponemal titers fail to decline fourfold within 12-24 months for late latent syphilis
  • Signs or symptoms of syphilis develop

Retreatment

  • Benzathine penicillin G 2.4 million units IM weekly for 3 weeks, unless CSF examination indicates neurosyphilis 2
  • Perform CSF examination before retreatment to exclude neurosyphilis 2

Special Populations

HIV-Infected Patients

  • Use same treatment regimens as HIV-negative patients 2, 1
  • More frequent follow-up (every 3 months) is prudent 3
  • Consider CSF examination for late latent syphilis with RPR titers ≥1:32 or CD4 count <350 cells/mm³ 6
  • Single-dose benzathine penicillin G remains effective (76% serologic response at 6 months) 1

Pregnancy

  • Same penicillin regimens as non-pregnant patients 2
  • Penicillin-allergic pregnant patients must undergo desensitization—no alternative antibiotics are acceptable 2, 3
  • Screen three times: first prenatal visit, third trimester, and at delivery 7

Key Clinical Pitfalls

  • Do not use azithromycin in men who have sex with men, pregnant women, or as routine therapy due to widespread resistance 2
  • Do not perform routine CSF examination for primary or secondary syphilis without neurologic or ophthalmic symptoms 2
  • Do not use additional doses of penicillin beyond recommended regimens—they do not enhance efficacy 2
  • Nontreponemal titers decline more slowly in patients with prior syphilis—this does not indicate treatment failure 2
  • All patients with syphilis should be tested for HIV 2

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Guideline

Alternative Treatments for Syphilis and Gonorrhea in Penicillin-Allergic Patients

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Research

Management of adult syphilis.

Clinical infectious diseases : an official publication of the Infectious Diseases Society of America, 2011

Research

Syphilis: A Review.

JAMA, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.